Question

Difficulty: MediumEnd-of-Life and Palliative Care

A 68-year-old man is admitted to the inpatient palliative care unit due to progressive, severe dyspnea. He has stage IV non-small cell lung cancer with extensive pleural involvement and lymphangitic carcinomatosis. He is currently awake but visibly distressed, breathing at 32 breaths per minute. His oxygen saturation is 89% on room air. The patient has a 'Do Not Resuscitate / Do Not Intubate' (DNR/DNI) order in place, and his stated primary goal of care is maximum comfort.

Arrange the following interventions in the appropriate stepwise order of escalation for the management of this patient's terminal dyspnea, from the initial step to the final step for refractory symptoms.

  1. 1Implementation of non-pharmacologic measures (e.g., bedside fan, head elevation)
  2. 2Administration of oral or sublingual low-dose opioids (e.g., morphine)
  3. 3Initiation of a continuous parenteral opioid infusion
  4. 4Administration of palliative sedation (e.g., continuous midazolam infusion)

Answer

The appropriate stepwise escalation for terminal dyspnea begins with non-pharmacologic measures, proceeds to enteral opioids, escalates to continuous parenteral opioids, and utilizes palliative sedation only as a last resort.
The standard approach to managing dyspnea at the end of life follows a stepwise escalation. Non-pharmacologic measures are the foundation. When pharmacotherapy is needed, opioids are the treatment of choice, starting with intermittent oral or sublingual doses. For persistent or severe symptoms, continuous parenteral infusions are used. Palliative sedation is strictly reserved for refractory symptoms when all other measures fail.

Step-by-Step Solution

1
Implement non-pharmacologic interventions.
Bedside fan and positioning applied.
Provides immediate, non-invasive relief by stimulating trigeminal nerve receptors and reducing the work of breathing.
2
Initiate first-line pharmacologic therapy.
Oral or sublingual morphine administered.
Opioids are the gold standard for treating dyspnea in advanced illness, acting to decrease central respiratory drive and alter the perception of breathlessness.
3
Escalate the opioid delivery method if symptoms persist.
Continuous intravenous or subcutaneous opioid infusion started.
Parenteral continuous delivery ensures steady-state relief for severe, progressive dyspnea that is unresponsive to intermittent dosing.
4
Consider therapy of last resort for refractory symptoms.
Palliative sedation with midazolam initiated.
Used exclusively when dyspnea remains unbearable despite maximal optimal opioid therapy, aiming to lower consciousness to relieve suffering.

Key Concept

Stepwise management of terminal dyspnea in palliative care
Rate this question